WHO/HIV/2014.27
© World Health Organization 2014
Appendix 6: Summary of declared interests of members of Guidelines Development Group for the development of WHO HCV guidelines for screening, care, and treatment of persons with HCV infection
Participants Declared interests Level of Participation
Vladimir
Personal: Travel grants from Bristol Myers Squibb (BMS)
Partial participation Chulanov Institutional: Research grants from BMS
Wahid Doss Personal: Travel grant from Abbott Full participation Institutional: Research grant from Gilead
Nicolas Durier Personal: None Full participation
Intstitutional: Drug donation from Merck Manal Hamdy El-
Personal: Travel grants Merck and Roche and speakers'
Partial participation
Sayed honorarium from Merck
Institutional:
Charles Gore Personal: None Partial participation
Institutional: President of World Hepatitis Alliance that
receives grants from Achillion, Bayer, BMS, Boehringer
Ingelheim, Gilead, GSK, Janssen, Merck, Roche Anna Lok
Personal: Consulting fees from Achilon, Astex, Bayer, BMS,
Partial participation Glaxo Smith Kline (GSK), Gilead, Janssen, Novartis,
Merck, Roche
Institutional: Research grants from Abbott, BMS, Gilead, GSK, Merck, Roche
Masashi
Personal: Holder of patent for hepatitis diagnostic test
Partial participation Mizokami
John Parry Personal: None Full participation
Institutional: Research grants from Gilead and Ireland Fellowship Program
Shiv Kumar Sarin Personal: None Full participation
Institutional: Research grants from Indian government
research institutions
Tracy Swan Personal: None Full participation
Institutional: Employing institution receives numerous
individual contributions and institutional grants.
Among these
are grants from BMS, Boehringer Ingelheim, Genentech,
Gilead, Janssen, Vertex